Veneroni, Chiara
Ramaswamy, Viraraghavan Vadakkencherry
Gray, Diane M.
Dellacà, Raffaele L.
Lavizzari, Anna
Pullattayil, Abdul Kareem
Rigotti, Camilla
Ventura, Maria Luisa
Zannin, Emanuela
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (PNC0000003)
Article History
Received: 11 December 2025
Revised: 1 March 2026
Accepted: 13 March 2026
First Online: 6 May 2026
Competing interests
: Politecnico di Milano University, Institution of C.V. and R.L.D., received grants from Restech, Philips Healthcare, and Zoll Medical; R.L.D. holds a patent for the detection of expiratory flow limitation by oscillometry, for which royalties are paid by Philips Respironics and Restech srl outside the submitted work; a patent on monitoring lung volume recruitment by oscillometry with royalties paid by Zoll Medical; a patent on early detection of exacerbations by home monitoring of oscillometry with royalties paid by Restech, outside the submitted work; he is co-founder and shareholder of Restech Srl, a spin-off company of Politecnico di Milano producing medical devices for lung function testing based on oscillometry. A.L. reports to be a consultant for Chiesi Farmaceutici S.p.A., Zoll Medical, and Getinge. The other authors have nothing to disclose.